eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
2/2024
vol. 26
 
Share:
Send email
Share:
Original paper

Assessment of anti-HBs level in serum of future healthcare workers in terms of hepatitis B infection prevention

Laura Zawiła
1
,
Małgorzata M. Kozioł
2

  1. Students Scientific Association at the Chair and Department of Medical Microbiology, Medical University of Lublin, Lublin, Poland
  2. Chair and Department of Medical Microbiology, Medical University of Lublin, Poland
Family Medicine & Primary Care Review 2024; 26(2): 246–250
DOI: https://doi.org/10.5114/fmpcr.2024.139037
Online publish date: 2024/06/17
Article file
- 16 FM&PCR 2 24 - O - Zawiła - 1508 - Assessment.pdf  [0.46 MB]
Get citation
 
PlumX metrics:
 
1. Nguyen MH, Wong G, Gane E, et al. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clin Microbiol Rev 2020; 33(2): e00046-19, doi: 10.1128/CMR.00046-19.
2. World Health organization [Internet]. Hepatitis B [cited 06.05.2023]. Available from URL: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
3. World Health Organization. Global Hepatitis Report 2017. Available from URL: https://iris.who.int/bitstream/handle/10665/255016 /9789241565455-eng.pdf?sequence=1.
4. Aspinall EJ, Hawkins G, Fraser A, et al. Hepatitis B prevention, diagnosis, treatment and care: a review. Occup Med (Chic Ill) 2011; 61(8): 531–540.
5. Liaw Y-F, Chu C-M. Hepatitis B virus infection. Lancet 2009; 373(9663): 582–592.
6. Burns GS, Thompson AJ. Viral hepatitis B: clinical and epidemiological characteristics. Cold Spring Harb Perspect Med 2014; 4(12): a024935.
7. World Health Organization. Global health sector strategy on viral hepatitis 2016–2021. 2016. Available from URL: https://iris.who.int/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf?sequence=1
8. World Health Organization. Global Health Sector Strategies on, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022–2030. 2022. Available from URL: https://iris.who.int/bitstream/handle/10665/360348/9789240053779-eng.pdf?sequence=1.
9. Zhao H, Zhou X, Zhou Y-H. Hepatitis B vaccine development and implementation. Hum Vaccin Immunother 2020; 16(7): 1533–1544.
10. Szczepienia. Info [Internet]. Szczepionka przeciw WZW B [cited 28.03.2023]. Available from URL: https://szczepienia.pzh.gov.pl/szczepionki/wzw-b/?strona=1#podsumowanie---szczepionka-przeciw-wzw-b (in Polish).
11. Leuridan E, Van Damme P. Hepatitis B and the Need for a Booster Dose. Clin Infect Dis 2011; 53(1): 68–75.
12. Bruce MG, Bruden D, Hurlburt D, et al. Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose. J Infect Dis 2016; 214(1): 16–22.
13. Lu I-C, Jean M-CY, Lin C-W, et al. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine. Medicine (Baltimore) 2016; 95(39): e5023.
14. Coppola N. Hepatitis B virus and hepatitis C virus infection in healthcare workers. World J Hepatol 2016; 8(5): 273.
15. Schillie S, Vellozzi C, Reingold A, et al. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Reports 2018; 67(1): 1–31.
16. Bianchi FP, Gallone MS, Gallone MF, et al. HBV seroprevalence after 25 years of universal mass vaccination and management of non-responders to the anti-Hepatitis B vaccine: An Italian study among medical students. J Viral Hepat 2019; 26(1): 136–144.
17. Tosun S, Deveci S, Kaplan Y, et al. Should a booster dose be administered in children after mass immunization for hepatitis B? Hepat Mon 2011; 11(6): 440–444.
18. Pileggi C, Papadopoli R, Bianco A, et al. Hepatitis B vaccine and the need for a booster dose after primary vaccination. Vaccine 2017; 35(46): 6302–6307.
19. Al Ghamdi SS, Fallatah HI, Fetyani DM, et al. Long-term efficacy of the hepatitis B Vaccine in a high-risk group. J Med Virol 2013; 85(9): 1518–1522.
20. Schmid K, Schwager C, Drexler H. Needlestick injuries and other occupational exposures to body fluids amongst employees and medical students of a German university: incidence and follow-up. J Hosp Infect 2007; 65(2): 124–130.
21. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018; 67(4): 1560–1599.
22. Vivian Efua S-D, Armah D, Delali Adwoa W. Hepatitis B virus vaccination post serological testing and antibody levels of vaccinated health care workers in Accra, Ghana. Vaccine X 2023; 14: 100294.
23. McMahon BJ, Dentinger CM, Bruden D, et al. Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22‐Year Follow‐Up Study and Response to a Booster Dose. J Infect Dis 2009; 200(9): 1390–1396.
24. Varshochi M, Haghdoost M. Evaluating the effect of booster dose of Hepatitis B vaccine in low-and non-responders healthcare workers and the role of some host-related factors. Am J Immunol 2011; 7(2): 24–28.
Copyright: © 2024 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.